All Stories

  1. The Impact of Lipoprotein Apheresis on Inflammatory Factors: A Systematic Review and Meta‐Analysis
  2. Optimized Method for the Use of Polyethylene Glycol as Embedding Medium for Histological Studies
  3. Analysis of Mutational Burden of Mitochondrial Genome in Cells of Different Human Organs and Tissues
  4. Is Oxidized Low-Density Lipoprotein a Principal Actor in Atherogenesis?
  5. Mitochondrial Dysfunction Associated with mtDNA Mutation: Mitochondrial Genome Editing in Atherosclerosis Research
  6. Rheumatoid Arthritis: What Inflammation Do We Face?
  7. Use of Olives-derived Phytochemicals for Prevention and Treatment of Atherosclerosis: An Update
  8. Mitochondrial Dysfunction in Systemic Lupus Erythematosus: Insights and Therapeutic Potential
  9. Vitamin D in Primary Sjogren’s Syndrome (pSS) and the Identification of Novel Single-Nucleotide Polymorphisms Involved in the Development of pSS-Associated Diseases
  10. Role of Cathelicidins in Atherosclerosis and Associated Cardiovascular Diseases
  11. Molecular Aspects of Inflammation and Lipid Metabolism in Health and Disease: The Role of the Mitochondria
  12. Cholesteryl Ester Transfer Protein Variations and Cardiovascular Diseases
  13. Mitochondrial Genome Editing: Exploring the Possible Relationship of the Atherosclerosis-Associated Mutation m.15059G>A With Defective Mitophagy
  14. Is There a Relationship between Adverse Pregnancy Outcomes and Future Development of Atherosclerosis?
  15. Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel Disease
  16. Potential Application of the Plant-Derived Essential Oils for Atherosclerosis Treatment: Molecular Mechanisms and Therapeutic Potential
  17. Atheroprotective Aspects of Heat Shock Proteins
  18. Oligosaccharides as Potential Therapeutics against Atherosclerosis
  19. The Role of Selenium in Atherosclerosis Development, Progression, Prevention and Treatment
  20. Condition “Vasa Vasorum” in Patients with Thoracic Aortic Aneurysm
  21. Impaired Mitochondrial Function in T-Lymphocytes as a Result of Exposure to HIV and ART
  22. HDL-Based Therapy: Vascular Protection at All Stages
  23. Hypotheses on Atherogenesis Triggering: Does the Infectious Nature of Atherosclerosis Development Have a Substruction?
  24. Creation of Mitochondrial Disease Models Using Mitochondrial DNA Editing
  25. Proprotein Convertase Subtilisin/Kexin 9 as a Modifier of Lipid Metabolism in Atherosclerosis
  26. The Role of Macrophages in the Pathogenesis of Atherosclerosis
  27. Mechanisms of the Wnt Pathways as a Potential Target Pathway in Atherosclerosis
  28. Sialic acid as the potential link between lipid metabolism and inflammation in the pathogenesis of atherosclerosis
  29. Targeting Mitochondrial Dynamics Proteins for the Development of Therapies for Cardiovascular Diseases
  30. Significance of Mitochondrial Dysfunction in the Progression of Multiple Sclerosis
  31. Effect of Glucose Levels on Cardiovascular Risk
  32. Atherosclerosis Specific Features in Chronic Kidney Disease (CKD)
  33. From Diabetes to Atherosclerosis: Potential of Metformin for Management of Cardiovascular Disease
  34. The Role of Mitochondrial Abnormalities in Diabetic Cardiomyopathy
  35. Aging of Vascular System Is a Complex Process: The Cornerstone Mechanisms
  36. Interplay between Zn2+ Homeostasis and Mitochondrial Functions in Cardiovascular Diseases and Heart Ageing
  37. Cholesterol Transport Dysfunction and Its Involvement in Atherogenesis
  38. Modulating mTOR Signaling as a Promising Therapeutic Strategy for Atherosclerosis
  39. Molecular Pathogenesis and the Possible Role of Mitochondrial Heteroplasmy in Thoracic Aortic Aneurysm
  40. Genetic and Epigenetic Biomarkers for Diagnosis, Prognosis and Treatment of Metabolic Syndrome
  41. Genetic and Epigenetic Biomarkers for Diagnosis, Prognosis, and Treatment of Global Diseases
  42. The role of endoplasmic reticulum stress in atherosclerosis
  43. Thoracic Aortic Aneurysm and Factors Affecting Aortic Dissection
  44. Lipid Metabolism in Macrophages: Focus on Atherosclerosis
  45. Endoplasmic Reticulum Stress in Macrophages: The Vicious Circle of Lipid Accumulation and Pro-Inflammatory Response
  46. Cell and tissue markers of atherosclerosis
  47. Cholesterol metabolism in macrophages
  48. Signaling Pathways Potentially Responsible for Foam Cell Formation: Cholesterol Accumulation or Inflammatory Response—What is First?
  49. Signaling Pathways and Key Genes Involved in Regulation of foam Cell Formation in Atherosclerosis
  50. Role of Phagocytosis in the Pro-Inflammatory Response in LDL-Induced Foam Cell Formation; a Transcriptome Analysis
  51. Atherosclerosis prevention the role of special diets and functional food
  52. Prevention of atherosclerosis the role of special diets and functional foods
  53. Heteroplasmic Variants of Mitochondrial DNA in Atherosclerotic Lesions of Human Aortic Intima
  54. Genetic and Molecular Approaches to Drug Target Discovery for Treatment of the most Dangerous Diseases that are Rapidly Increasing Globally. Part II
  55. Genetic and Molecular Approaches to Drug Target Discovery for Treatment of the most Dangerous Diseases that are Rapidly Increasing Globally. Part I
  56. Transcriptional Characteristics of Activated Macrophages
  57. Glycosylation of human plasma lipoproteins reveals a high level of diversity, which directly impacts their functional properties
  58. The role of physical activity in the development of atherosclerotic lesions of the vascular wall
  59. Translation of Basic Research into Clinical Practice: Focus on Cell-Based Diagnostics and Therapy
  60. Diagnostics and Therapy of Human Diseases - Focus on Sialidases
  61. Current Approaches to Diagnostics and Therapies of Chronic Diseases: Focus on Molecular and Cell Biology
  62. HDL activates expression of genes stimulating cholesterol efflux in human monocyte-derived macrophages
  63. Sialidases: Therapeutic and Antiatherogenic Potential
  64. HDL-Targeting Therapeutics: Past, Present and Future
  65. Multiple-modified Low-Density Lipoprotein as Atherogenic Factor of Patients'; Blood: Development of Therapeutic Approaches to Reduce Blood Atherogenicity
  66. Poor glycemic control in type 2 diabetes enhances functional and compositional alterations of small, dense HDL3c
  67. Analysis of Apolipoprotein B Protein of Circulating Multiple-Modified Low-Density Lipoprotein
  68. Carbohydrate composition of circulating multiple-modified low-density lipoprotein
  69. Lipid composition of circulating multiple-modified low density lipoprotein
  70. Epigenetic factors in atherogenesis: MicroRNA
  71. Epigenetic factors in atherogenesis: microRNA
  72. Atherogenic modification of low-density lipoproteins
  73. Neuron density in the hippocampus in rat strains with contrasting nervous system excitability after prolonged emotional-pain stress